Chronic lithium administration attenuates up-regulated brain arachidonic acid metabolism in a rat model of neuroinflammation

Journal of Neurochemistry

Volumn 102, Issue 3, 2007, Pages 761-772

  Basselin, Mireille ^a   Villacreses, Nelly E ^a   Lee, Ho Joo ^a   Bell, Jane M ^a   Rapoport, Stanley I ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Arachidonic acid; Lipopolysaccharide; Lithium; Neuroinflammation; Neuroprotection; Phospholipase A2

Indexed keywords

LIPOPOLYSACCHARIDE; LITHIUM CHLORIDE; PHOSPHOLIPASE A2; PROSTAGLANDIN E2; THROMBOXANE B2;

ANIMAL EXPERIMENT; ARACHIDONIC ACID METABOLISM; ARTICLE; AUDITORY SYSTEM; BRAIN CELL; BRAIN REGION; CEREBROSPINAL FLUID; CHRONIC DRUG ADMINISTRATION; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOPLASM; DIET; ENCEPHALITIS; ENZYME ACTIVITY; HYPOTHESIS; MALE; NEUROMODULATION; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT; STATISTICAL SIGNIFICANCE; TREATMENT DURATION; UPREGULATION; VISUAL SYSTEM;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIMANIC AGENTS; ARACHIDONIC ACID; BIOLOGICAL MARKERS; BRAIN; DINOPROSTONE; DISEASE MODELS, ANIMAL; DOWN-REGULATION; DRUG ADMINISTRATION SCHEDULE; ENCEPHALITIS; LIPOPOLYSACCHARIDES; LITHIUM CHLORIDE; MALE; PHOSPHOLIPASES A; RATS; RATS, INBRED F344; THROMBOXANE B2; TREATMENT OUTCOME; UP-REGULATION;

RATTUS;

EID: 34447325887     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2007.04593.x     Document Type: Article

References (103)

1. Abe K., Kogure K., Yamamoto H., Imazawa M. Miyamoto K. (1987) Mechanism of arachidonic acid liberation during ischemia in gerbil cerebral cortex. J. Neurochem. 48, 503 509.
2. Anton R. F., Wallis C. Randall C. L. (1983) In vivo regional levels of PGE and thromboxane in mouse brain: effect of decapitation, focused microwave fixation, and indomethacin. Prostaglandins 26, 421 429.
3. Basselin M., Chang L., Seemann R., Bell J. M. Rapoport S. I. (2003) Chronic lithium administration potentiates brain arachidonic acid signaling at rest and during cholinergic activation in awake rats. J. Neurochem. 85, 1553 1562.
4. Basselin M., Chang L., Bell J. M. Rapoport S. I. (2005) Chronic lithium chloride administration to unanesthetized rats attenuates brain dopamine D2-like receptor-initiated signaling via arachidonic acid. Neuropsychopharmacology 30, 1064 1075.
5. Basselin M., Chang L., Bell J. M. Rapoport S. I. (2006a) Chronic lithium chloride administration attenuates brain NMDA receptor-initiated signaling via arachidonic acid in unanesthetized rats. Neuropsychopharmacology 31, 1659 1674.
6. Basselin M., Villacreses N. E., Langenbach R., Ma K., Bell J. M. Rapoport S. I. (2006b) Resting and arecoline-stimulated brain metabolism and signaling involving arachidonic acid are altered in the cyclooxygenase-2 knockout mouse. J. Neurochem. 96, 669 679.
7. Bazan N. G., Rodriguez de Turco E. B. Allan G. (1995) Mediators of injury in neurotrauma: intracellular signal transduction and gene expression. J. Neurotrauma. 12, 791 814.
8. Bazinet R. P., Lee H. J., Felder C. C., Porter A. C., Rapoport S. I. Rosenberger T. A. (2005) Rapid high-energy microwave fixation is required to determine the anandamide (N-arachidonoylethanolamine) concentration of rat brain. Neurochem. Res. 30, 597 601.
9. Bazinet R. P., Weis M. T., Rapoport S. I. Rosenberger T. A. (2006a) Valproic acid selectively inhibits conversion of arachidonic acid to arachidonoyl-CoA by brain microsomal long-chain fatty acyl-CoA synthetases: relevance to bipolar disorder. Psychopharmacology (Berl.) 184, 122 129.
10. Bazinet R. P., Rao J. S., Chang L., Rapoport S. I. Lee H. J. (2006b) Chronic carbamazepine decreases the incorporation rate and turnover of arachidonic acid but not docosahexaenoic acid in brain phospholipids of the unanesthetized rat: relevance to bipolar disorder. Biol. Psychiatry 59, 401 407.
11. Bezzi P., Carmignoto G., Pasti L., Vesce S., Rossi D., Rizzini B. L., Pozzan T. Volterra A. (1998) Prostaglandins stimulate calcium-dependent glutamate release in astrocytes. Nature 391, 281 285.
12. Bezzi P., Domercq M., Brambilla L. et al. (2001) CXCR4-activated astrocyte glutamate release via TNFalpha: amplification by microglia triggers neurotoxicity. Nat. Neurosci. 4, 702 710.
13. Bosetti F., Seemann R., Bell J. M., Zahorchak R., Friedman E., Rapoport S. I. Manickam P. (2002a) Analysis of gene expression with cDNA microarrays in rat brain after 7 and 42 days of oral lithium administration. Brain Res. Bull. 57, 205 209.
14. Bosetti F., Rintala J., Seemann R., Rosenberger T. A., Contreras M. A., Rapoport S. I. Chang M. C. (2002b) Chronic lithium downregulates cyclooxygenase-2 activity and prostaglandin E2 concentration in rat brain. Mol. Psychiatry 7, 845 850.
15. Bosetti F., Weerasinghe G. R., Rosenberger T. A. Rapoport S. I. (2003) Valproic acid down-regulates the conversion of arachidonic acid to eicosanoids via cyclooxygenase-1 and -2 in rat brain. J. Neurochem. 85, 690 696.
16. Bosetti F., Langenbach R. Weerasinghe G. R. (2004) Prostaglandin E2 and microsomal prostaglandin E synthase-2 expression are decreased in the cyclooxygenase-2-deficient mouse brain despite compensatory induction of cyclooxygenase-1 and Ca2+-dependent phospholipase A2. J. Neurochem. 91, 1389 1397.
17. Bosisio E., Galli C., Galli G., Nicosia S., Spagnuolo C. Tosi L. (1976) Correlation between release of free arachidonic acid and prostaglandin formation in brain cortex and cerebellum. Prostaglandins 11, 773 781.
18. Bradford M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248 254.
19. Brodal A. (1981) Neurological Anatomy in Relation to Clinical Medicine, 3rd edn. Oxford University Press, Oxford.
20. Chang M. C. Jones C. R. (1998) Chronic lithium treatment decreases brain phospholipase A2 activity. Neurochem. Res. 23, 887 892.
21. Chang M. C., Grange E., Rabin O., Bell J. M., Allen D. D. Rapoport S. I. (1996) Lithium decreases turnover of arachidonate in several brain phospholipids. Neurosci. Lett. 220, 171 174.
22. Chang M. C., Contreras M. A., Rosenberger T. A., Rintala J. J., Bell J. M. Rapoport S. I. (2001a) Chronic valproate treatment decreases the in vivo turnover of arachidonic acid in brain phospholipids: a possible common effect of mood stabilizers. J. Neurochem. 77, 796 803.
23. Chang R. C., Chen W., Hudson P., Wilson B., Han D. S. Hong J. S. (2001b) Neurons reduce glial responses to lipopolysaccharide (LPS) and prevent injury of microglial cells from over-activation by LPS. J. Neurochem. 76, 1042 1049.
24. Choi S. H., Langenbach R. Bosetti F. (2006) Cyclooxygenase-1 and -2 enzymes differentially regulate the brain upstream NF-kappaB pathway and downstream enzymes involved in prostaglandin biosynthesis. J. Neurochem. 98, 801 811.
25. Chuang D. M., Chen R. W., Chalecka-Franaszek E., Ren M., Hashimoto R., Senatorov V., Kanai H., Hough C., Hiroi T. Leeds P. (2002) Neuroprotective effects of lithium in cultured cells and animal models of diseases. Bipolar Disord. 4, 129 136.
26. Corsini E., Dufour A., Ciusani E., Gelati M., Frigerio S., Gritti A., Cajola L., Mancardi G. L., Massa G. Salmaggi A. (1996) Human brain endothelial cells and astrocytes produce IL-1 beta but not IL-10. Scand. J. Immunol. 44, 506 511.
27. DeMar J. C. Jr., Ma K., Bell J. M. Rapoport S. I. (2004) Half-lives of docosahexaenoic acid in rat brain phospholipids are prolonged by 15 weeks of nutritional deprivation of n-3 polyunsaturated fatty acids. J. Neurochem. 91, 1125 1137.
28. Descamps L., Cecchelli R. Torpier G. (1997) Effects of tumor necrosis factor on receptor-mediated endocytosis and barrier functions of bovine brain capillary endothelial cell monolayers. J. Neuroimmunol. 74, 173 184.
29. Deutsch J., Rapoport S. I. Purdon A. D. (1997) Relation between free fatty acid and acyl-CoA concentrations in rat brain following decapitation. Neurochem. Res. 22, 759 765.
30. Dinarello C. A. (2002) The IL-1 family and inflammatory diseases. Clin. Exp. Rheumatol. 20, S1 S13.
31. Dirnagl U., Iadecola C. Moskowitz M. A. (1999) Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 22, 391 397.
32. Dorman R. V. (1988) Effects of cerebral ischemia and reperfusion on prostanoid accumulation in unanesthetized and pentobarbital-treated gerbils. J. Cereb. Blood Flow Metab. 8, 609 612.
33. Dumuis A., Sebben M., Haynes L., Pin J. P. Bockaert J. (1988) NMDA receptors activate the arachidonic acid cascade system in striatal neurons. Nature 336, 68 70.
34. Esposito G., Giovacchini G., Der M. et al. (2007) Imaging signal transduction via arachidonic acid in the human brain during visual stimulation, by means of positron emission tomography. Neuroimage. 34, 1342 1351.
35. Fafeur V., Jiang Z. P. Bohlen P. (1991) Signal transduction by bFGF, but not TGF beta 1, involves arachidonic acid metabolism in endothelial cells. J. Cell. Physiol. 149, 277 283.
36. Folch J., Lees M. Sloane Stanley G. H. (1957) A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 226, 497 509.
37. Ghelardoni S., Tomita Y. A., Bell J. M., Rapoport S. I. Bosetti F. (2004) Chronic carbamazepine selectively downregulates cytosolic phospholipase A2 expression and cyclooxygenase activity in rat brain. Biol. Psychiatry 56, 248 254.
38. Giovacchini G., Chang M. C., Channing M. A. et al. (2002) Brain incorporation of [11C]arachidonic acid in young healthy humans measured with positron emission tomography. J. Cereb. Blood Flow Metab. 22, 1453 1462.
39. Giovacchini G., Lerner A., Toczek M. T., Fraser C., Ma K., DeMar J. C., Herscovitch P., Eckelman W. C., Rapoport S. I. Carson R. E. (2004) Brain incorporation of [11C]arachidonic acid, blood volume, and blood flow in healthy aging: a study with partial-volume correction. J. Nucl. Med. 45, 1471 1479.
40. Glezer I., Munhoz C. D., Kawamoto E. M., Marcourakis T., Avellar M. C. Scavone C. (2003) MK-801 and 7-Ni attenuate the activation of brain NF-kappa B induced by LPS. Neuropharmacology 45, 1120 1129.
41. Goralski K. B., Abdulla D., Sinal C. J., Arsenault A. Renton K. W. (2005) Toll-like receptor-4 regulation of hepatic Cyp3a11 metabolism in a mouse model of LPS-induced CNS inflammation. Am. J. Physiol. Gastrointest. Liver Physiol. 289, G434 G443.
42. Hardardottir I., Grunfeld C. Feingold K. R. (1994) Effects of endotoxin and cytokines on lipid metabolism. Curr. Opin. Lipidol. 5, 207 215.
43. Hauss-Wegrzyniak B., Lukovic L., Bigaud M. Stoeckel M. E. (1998a) Brain inflammatory response induced by intracerebroventricular infusion of lipopolysaccharide: an immunohistochemical study. Brain Res. 794, 211 224.
44. Hauss-Wegrzyniak B., Dobrzanski P., Stoehr J. D. Wenk G. L. (1998b) Chronic neuroinflammation in rats reproduces components of the neurobiology of Alzheimer's disease. Brain Res. 780, 294 303.
45. Hauss-Wegrzyniak B., Willard L. B., Del Soldato P., Pepeu G. Wenk G. L. (1999) Peripheral administration of novel anti-inflammatories can attenuate the effects of chronic inflammation within the CNS. Brain Res. 815, 36 43.
46. Hunot S. Hirsch E. C. (2003) Neuroinflammatory processes in Parkinson's disease. Ann. Neurol. 53 (Suppl. 3 S49 S58.
47. Iadecola C., Niwa K., Nogawa S., Zhao X., Nagayama M., Araki E., Morham S. Ross M. E. (2001) Reduced susceptibility to ischemic brain injury and N-methyl-D-aspartate-mediated neurotoxicity in cyclooxygenase-2-deficient mice. Proc. Natl Acad. Sci. USA 98, 1294 1299.
48. Ikeda-Matsuo Y., Ikegaya Y., Matsuki N., Uematsu S., Akira S. Sasaki Y. (2005) Microglia-specific expression of microsomal prostaglandin E2 synthase-1 contributes to lipopolysaccharide-induced prostaglandin E2 production. J. Neurochem. 94, 1546 1558.
49. Jung H. Reme C. (1994) Light-evoked arachidonic acid release in the retina: illuminance/duration dependence and the effects of quinacrine, mellitin and lithium. Light-evoked arachidonic acid release. Graefes Arch. Clin. Exp. Ophthalmol. 232, 167 175.
50. Kim W. G., Mohney R. P., Wilson B., Jeohn G. H., Liu B. Hong J. S. (2000) Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia. J. Neurosci. 20, 6309 6316.
51. Kramer R. M. Sharp J. D. (1997) Structure, function and regulation of Ca2+-sensitive cytosolic phospholipase A2 (cPLA2). FEBS Lett. 410, 49 53.
52. Lampe H. Bigalke H. (1990) Carbamazepine blocks NMDA-activated currents in cultured spinal cord neurons. Neuroreport 1, 26 28.
53. Lee J. M., Grabb M. C., Zipfel G. J. Choi D. W. (2000) Brain tissue responses to ischemia. J. Clin. Invest. 106, 723 731.
54. Lee H., Villacreses N. E., Rapoport S. I. Rosenberger T. A. (2004) In vivo imaging detects a transient increase in brain arachidonic acid metabolism: a potential marker of neuroinflammation. J. Neurochem. 91, 936 945.
55. Lehnardt S., Lachance C., Patrizi S., Lefebvre S., Follett P. L., Jensen F. E., Rosenberg P. A., Volpe J. J. Vartanian T. (2002) The toll-like receptor TLR4 is necessary for lipopolysaccharide-induced oligodendrocyte injury in the CNS. J. Neurosci. 22, 2478 2486.
56. Lehnardt S., Massillon L., Follett P., Jensen F. E., Ratan R., Rosenberg P. A., Volpe J. J. Vartanian T. (2003) Activation of innate immunity in the CNS triggers neurodegeneration through a toll-like receptor 4-dependent pathway. Proc. Natl Acad. Sci. USA 100, 8514 8519.
57. Li S., Ballou L. R., Morham S. G. Blatteis C. M. (2001) Cyclooxygenase-2 mediates the febrile response of mice to interleukin-1beta. Brain Res. 910, 163 173.
58. Luschen S., Adam D., Ussat S., Kreder D., Schneider-Brachert W., Kronke M. Adam-Klages S. (2000) Activation of ERK1/2 and cPLA(2) by the p55 TNF receptor occurs independently of FAN. Biochem. Biophys. Res. Commun. 274, 506 512.
59. Ma J. Zhang G. Y. (2003) Lithium reduced N-methyl-D-aspartate receptor subunit 2A tyrosine phosphorylation and its interactions with Src and Fyn mediated by PSD-95 in rat hippocampus following cerebral ischemia. Neurosci. Lett. 348, 185 189.
60. Ma J., Zhang G. Y., Liu Y., Yan J. Z. Hao Z. B. (2004) Lithium suppressed Tyr-402 phosphorylation of proline-rich tyrosine kinase (Pyk2) and interactions of Pyk2 and PSD-95 with NR2A in rat hippocampus following cerebral ischemia. Neurosci. Res. 49, 357 362.
61. Makrides M., Neumann M. A., Byard R. W., Simmer K. Gibson R. A. (1994) Fatty acid composition of brain, retina, and erythrocytes in breast- and formula-fed infants. Am. J. Clin. Nutr. 60, 189 194.
62. Martin E. D. Pozo M. A. (2004) Valproate reduced excitatory postsynaptic currents in hippocampal CA1 pyramidal neurons. Neuropharmacology 46, 555 561.
63. McGeer P. L. McGeer E. G. (2004) Inflammation and neurodegeneration in Parkinson's disease. Parkinsonism Relat. Disord. 10 (Suppl. 1 S3 S7.
64. Minghetti L. (2004) Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases. J. Neuropathol. Exp. Neurol. 63, 901 910.
65. Minghetti L. (2005) Role of inflammation in neurodegenerative diseases. Curr. Opin. Neurol. 18, 315 321.
66. Montine K. S., Quinn J. F., Zhang J., Fessel J. P., Roberts L. J. II., Morrow J. D. Montine T. J. (2004) Isoprostanes and related products of lipid peroxidation in neurodegenerative diseases. Chem. Phys. Lipids 128, 117 124.
67. Morri H., Ozaki M. Watanabe Y. (1994) 5′-flanking region surrounding a human cytosolic phospholipase A2 gene. Biochem. Biophys. Res. Commun. 205, 6 11.
68. Nadeau S. Rivest S. (1999) Effects of circulating tumor necrosis factor on the neuronal activity and expression of the genes encoding the tumor necrosis factor receptors (p55 and p75) in the rat brain: a view from the blood-brain barrier. Neuroscience 93, 1449 1464.
69. Nakamura Y., Ohmaki M., Murakami K. Yoneda Y. (2003) Involvement of protein kinase C in glutamate release from cultured microglia. Brain Res. 962, 122 128.
70. Nonaka S., Hough C. J. Chuang D. M. (1998) Chronic lithium treatment robustly protects neurons in the central nervous system against excitotoxicity by inhibiting N-methyl-D-aspartate receptor-mediated calcium influx. Proc. Natl Acad. Sci. USA 95, 2642 2647.
71. Patrizio M., Costa T. Levi G. (1995) Interferon-gamma and lipopolysaccharide reduce cAMP responses in cultured glial cells: reversal by a type IV phosphodiesterase inhibitor. Glia 14, 94 100.
72. Paxinos G. Watson C. (1987) The Rat Brain in Stereotaxic Coordinates, 3rd edn. Academic Press, New York.
73. Pepicelli O., Fedele E., Bonanno G., Raiteri M., Ajmone-Cat M. A., Greco A., Levi G. Minghetti L. (2002) In vivo activation of N-methyl-D-aspartate receptors in the rat hippocampus increases prostaglandin E2 extracellular levels and triggers lipid peroxidation through cyclooxygenase-mediated mechanisms. J. Neurochem. 81, 1028 1034.
74. Persson M., Brantefjord M., Hansson E. Ronnback L. (2005) Lipopolysaccharide increases microglial GLT-1 expression and glutamate uptake capacity in vitro by a mechanism dependent on TNF-alpha. Glia 51, 111 120.
75. Pettigrew L. C., Grotta J. C., Rhoades H. M. Wu K. K. (1989) Effect of thromboxane synthase inhibition on eicosanoid levels and blood flow in ischemic rat brain. Stroke 20, 627 632.
76. Pfeilschifter J., Reme C. Dietrich C. (1988) Light-induced phosphoinositide degradation and light-induced structural alterations in the rat retina are enhanced after chronic lithium treatment. Biochem. Biophys. Res. Commun. 156, 1111 1119.
77. Poddubiuk Z. M., Blumberg J. B. Kopin I. J. (1982) Brain prostaglandin content in rats sacrificed by decapitation vs focused microwave irradiation. Experientia 38, 987 988.
78. Preston J. E. (2001) Ageing choroid plexus-cerebrospinal fluid system. Microsc. Res. Tech. 52, 31 37.
79. Qin L., Li G., Qian X., Liu Y., Wu X., Liu B., Hong J. S. Block M. L. (2005) Interactive role of the toll-like receptor 4 and reactive oxygen species in LPS-induced microglia activation. Glia 52, 78 84.
80. Rabin O., Chang M. C., Grange E., Bell J., Rapoport S. I., Deutsch J. Purdon A. D. (1998) Selective acceleration of arachidonic acid reincorporation into brain membrane phospholipid following transient ischemia in awake gerbil. J. Neurochem. 70, 325 334.
81. Radin N. S. (1981) Extraction of tissue lipids with a solvent of low toxicity. Meth. Enzymol. 72, 5 7.
82. Rao J. S., Rapoport S. I. Bosetti F. (2005) Decrease in the AP-2 DNA-binding activity and in the protein expression of AP-2 alpha and AP-2 beta in frontal cortex of rats treated with lithium for 6 weeks. Neuropsychopharmacology 30, 2006 2013.
83. Rapoport S. I. (2001) In vivo fatty acid incorporation into brain phospholipids in relation to plasma availability, signal transduction and membrane remodeling. J. Mol. Neurosci. 16, 243 261.
84. Rapoport S. I., Chang M. C. Spector A. A. (2001) Delivery and turnover of plasma-derived essential PUFAs in mammalian brain. J. Lipid Res. 42, 678 685.
85. Richardson R. L., Kim E. M., Gardiner T. O'Hare E. (2005) Chronic intracerebroventricular infusion of lipopolysaccharide: effects of ibuprofen treatment and behavioural and histopathological correlates. Behav. Pharmacol. 16, 531 541.
86. Rintala J., Seemann R., Chandrasekaran K., Rosenberger T. A., Chang L., Contreras M. A., Rapoport S. I. Chang M. C. (1999) 85 kDa cytosolic phospholipase A2 is a target for chronic lithium in rat brain. Neuroreport 10, 3887 3890.
87. Robinson P. J., Noronha J., DeGeorge J. J., Freed L. M., Nariai T. Rapoport S. I. (1992) A quantitative method for measuring regional in vivo fatty-acid incorporation into and turnover within brain phospholipids: review and critical analysis. Brain Res. Brain Res. Rev. 17, 187 214.
88. Rosenberger T. A., Villacreses N. E., Contreras M. A., Bonventre J. V. Rapoport S. I. (2003) Brain lipid metabolism in the cPLA2 knockout mouse. J. Lipid Res. 44, 109 117.
89. Rosenberger T. A., Villacreses N. E., Hovda J. T., Bosetti F., Weerasinghe G., Wine R. N., Harry G. J. Rapoport S. I. (2004) Rat brain arachidonic acid metabolism is increased by a 6-day intracerebral ventricular infusion of bacterial lipopolysaccharide. J. Neurochem. 88, 1168 1178.
90. Rosi S., Vazdarjanova A., Ramirez-Amaya V., Worley P. F., Barnes C. A. Wenk G. L. (2006) Memantine protects against LPS-induced neuroinflammation, restores behaviorally-induced gene expression and spatial learning in the rat. Neuroscience 142, 1303 1315.
91. Savchenko V. L., McKanna J. A., Nikonenko I. R. Skibo G. G. (2000) Microglia and astrocytes in the adult rat brain: comparative immunocytochemical analysis demonstrates the efficacy of lipocortin 1 immunoreactivity. Neuroscience 96, 195 203.
92. Shimizu T. Wolfe L. S. (1990) Arachidonic acid cascade and signal transduction. J. Neurochem. 55, 1 15.
93. Skipski V. P., Good J. J., Barclay M. Reggio R. B. (1968) Quantitative analysis of simple lipid classes by thin-layer chromatography. Biochim. Biophys. Acta 152, 10 19.
94. Stephenson D. T., Lemere C. A., Selkoe D. J. Clemens J. A. (1996) Cytosolic phospholipase A2 (cPLA2) immunoreactivity is elevated in Alzheimer's disease brain. Neurobiol. Dis. 3, 51 63.
95. Tabachnick B. G. Fidell L. S. (2001) Computer-assisted Research Design and Analysis, pp. 184 188. Allyn and Bacon Edition, Boston.
96. Uchiumi D., Kobayashi M., Tachikawa T. Hasegawa K. (2004) Subcutaneous and continuous administration of lipopolysaccharide increases serum levels of triglyceride and monocyte chemoattractant protein-1 in rats. J. Periodontal Res. 39, 120 128.
97. Wang Y. S. White T. D. (1999) The bacterial endotoxin lipopolysaccharide causes rapid inappropriate excitation in rat cortex. J. Neurochem. 72, 652 660.
98. Weerasinghe G. R., Seemann R., Rapoport S. I. Bosetti F. (2003) Lithium chloride, administered chronically to rats, does not affect the fractional phosphorylation of brain cytosolic phospholipase A2, while reducing its net protein level. Brain Res. Bull. 59, 303 306.
99. Weerasinghe G. R., Rapoport S. I. Bosetti F. (2004) The effect of chronic lithium on arachidonic acid release and metabolism in rat brain does not involve secretory phospholipase A2 or lipoxygenase/cytochrome P450 pathways. Brain Res. Bull. 63, 485 489.
100. Weichel O., Hilgert M., Chatterjee S. S., Lehr M. Klein J. (1999) Bilobalide, a constituent of Ginkgo biloba, inhibits NMDA-induced phospholipase A2 activation and phospholipid breakdown in rat hippocampus. Naunyn Schmiedebergs Arch. Pharmacol. 360, 609 615.
101. Wenk G. L., Rosi S., McGann K. Hauss-Wegrzyniak B. (2002) A nitric oxide-donating flurbiprofen derivative reduces neuroinflammation without interacting with galantamine in the rat. Eur. J. Pharmacol. 453, 319 324.
102. Weydt P. Moller T. (2005) Neuroinflammation in the pathogenesis of amyotrophic lateral sclerosis. Neuroreport 16, 527 531.
103. Willard L. B., Hauss-Wegrzyniak B., Danysz W. Wenk G. L. (2000) The cytotoxicity of chronic neuroinflammation upon basal forebrain cholinergic neurons of rats can be attenuated by glutamatergic antagonism or cyclooxygenase-2 inhibition. Exp. Brain Res. 134, 58 65.